Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Salmon, M.
Right arrow Articles by Gordon, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salmon, M.
Right arrow Articles by Gordon, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 1999; 38: 1177-1183
© 1999 British Society for Rheumatology


Reviews

The role of apoptosis in systemic lupus erythematosus

M. Salmon and C. Gordon

Division of Immunity and Infection, The University of Birmingham, Birmingham B15 2TT, UK

Correspondence to: M. Salmon, Division of Immunity and Infection, Rheumatology Research Group, The Medical School, The University of Birmingham, Birmingham B15 2TT, UK.


    Introduction
 
When it was described by Kerr et al. [1], the phenomenon of apoptosis, or programmed cell death, was greeted with a resounding lack of interest. The importance of this phenomenon is such that it is now very difficult to pick up any journal in a biomedical field without finding at least one paper on the subject. It has become apparent that the process is ubiquitous, representing a vital part of growth and differentiation in all tissues. The fundamental mechanisms of apoptosis and the genes that control it are highly conserved between species as diverse as worms and humans [2, 3].

Immunological research in apoptosis has focused on three areas in particular: (1) the selection of new lymphocytes, both B and T cells, before antigen challenge [4–6]; (2) the regulation of clonal expansion and resolution, including the elimination of apoptotic cells . . . [Full Text of this Article]


    Apoptosis
 

    A question of tolerance
 

    Systemic lupus erythematosus as a disease of defective apoptosis
 

    Too much apoptosis?
 

    Somatic hypermutation and B-cell memory
 

    A conundrum
 

    Why is the clearance of apoptotic cells deficient in patients with SLE?
 

    A vicious circle of C1q
 

    Acknowledgments
 

    References
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
C C Mok and C S Lau
Pathogenesis of systemic lupus erythematosus
J. Clin. Pathol., July 1, 2003; 56(7): 481 - 490.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. C. Pickering and M. J. Walport
Links between complement abnormalities and systemic lupus erythematosus
Rheumatology, February 1, 2000; 39(2): 133 - 141.
[Full Text] [PDF]